Moreover, cytokines such as ILs (IL-2, IL-4, IL-6, IL-8, IL-10), GM-CSF, and TGF-β released by MSCs alter the innate and adaptative immune cell activation status to favour tumour development, and progression (58). This evidence concerns the gene TGFB1 and neoplasm.